Company Expands Headquarters and National Workforce to Accommodate Rapid Growth IRVINE, Calif.—Laboratory for Advanced Medicine (LAM), a clinical-stage medical technology company developing innovative technologies for the early diagnosis and intervention of cancers, today announced the commercialization of its revolutionary, non-invasive and highly accurate IvyGene test. IvyGene is designed...
from EMS via xlomafota13 on Inoreader https://ift.tt/2mkFLi3
via IFTTT
Δευτέρα 16 Ιουλίου 2018
Laboratory for Advanced Medicine commercializes non-invasive, artificial intelligence-based IvyGene Blood Test for early cancer detection
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.